PhuNgocTranMD

PubMed

• 20 citations
  Catheter-related right atrial thrombosis.
  Minh-Ha Tran, Tanya Wilcox, Phu N. Tran> ;The Journal of Vascular Access. 2020 May 1
• 9 citations
  Emerging Role of Direct Oral Anticoagulants in the Management of Heparin-Induced Thrombocytopenia:
  Phu N. Tran, Minh-Ha Tran> ;Clinical and Applied Thrombosis/hemostasis. 2018 Mar 1
• 31 citations
  Cobalamin deficiency presenting with thrombotic microangiopathy (TMA) features: A systematic review.
  Phu N. Tran, Minh-Ha Tran> ;Transfusion and Apheresis Science. 2018 Feb 1
• 16 citations
  Physician Beware: Severe Cyanide Toxicity from Amygdalin Tablets Ingestion.
  Tam Dang, Cham Nguyen, Phu N. Tran> ;Case Reports in Emergency Medicine. 2017 Aug 24
• 31 citations
  Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non–small cell lung cancer
  Ahmad A. Tarhini, Imran Rafique, Theofanis Floros, Phu Tran, William E. Gooding, Liza C. Villaruz, Timothy F. Burns, David M. Friedland, Daniel P. Petro, Mariya Farooq...> ;Cancer. 2017 Aug 1
• 8 citations
  The safety of Bruton's tyrosine kinase inhibitors for the treatment of chronic lymphocytic leukemia.
  Phu N. Tran, Susan O'Brien> ;Expert Opinion on Drug Safety. 2017 Jun 23
• MLL-rearranged mixed phenotype acute leukemia masquerading as B-cell ALL
  Wei Yang, Phu N. Tran, Ziad U. Khan, Sherif Rezk, Susan O'Brien> ;Leukemia & Lymphoma. 2017 Jun 1
• 33 citations
  PD-1 and PD-L1 as emerging therapeutic targets in gastric cancer: current evidence.
  Phu N. Tran, Sarmen Sarkissian, Joseph Chao, Samuel J. Klempner> ;Gastrointestinal Cancer. 2017 May 5
• 2 citations
  ALK on my mind: alectinib takes an early lead in managing intracranial disease in non-small cell lung cancer with ALK rearrangements.
  Phu N. Tran, Samuel J. Klempner> ;Annals of Translational Medicine. 2017 Apr 1
• 18 citations
  The impact of gender, race, socioeconomic status, and treatment on outcomes in esophageal cancer: A population-based analysis
  Phu N. Tran, Thomas H. Taylor, Samuel J. Klempner, Jason A. Zell> ;Journal of Carcinogenesis. 2017 Jan 1
• 3 citations
  Cytarabine Induced Acute Cerebellar Syndrome during Hyper-CVAD Treatment for B-Cell Acute Lymphoblastic Leukemia.
  Phu N. Tran, Xiao-Tang Kong> ;Case Reports in Neurology. 2017 Jan 1
• 4 citations
  Dramatic Response to Carboplatin, Paclitaxel, and Radiation in a Patient With Malignant Myoepithelioma of the Breast.
  Phu N. Tran, Lefan Zhuang, Chaital i Nangia, Rita S. Mehta> ;The Oncologist. 2016 Dec 1
• 8 citations
  Focus on Alectinib and Competitor Compounds for Second-Line Therapy in ALK-Rearranged NSCLC
  Phu N. Tran, Samuel J. Klempner> ;Frontiers in Medicine. 2016 Nov 30
• 17 citations
  Targeting the Phosphatidylinositol-3-kinase Pathway in Gastric Cancer: Can Omics Improve Outcomes?
  Phu N. Tran, Cham Nguyen, Samuel J. Klempner> ;International Neurourology Journal. 2016 Nov 22
• 8 citations
  Profile of rociletinib and its potential in the treatment of non-small-cell lung cancer.
  Phu N. Tran, Samuel J. Klempner> ;Lung Cancer. 2016 Jul 18
• 65 citations
  BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF–MEK Combination Therapy
  Samuel J. Klempner, Bruce G. Gershenhorn, Phu N. Tran, Thomas K. Lee, Mark G. Erlander, Kyle Gowen, Alexa B. Schrock, Deborah Morosini, Jeffrey S. Ross, Vincent A. Mil...> ;Cancer Discovery. 2016 Jun 1
• 12 citations
  Multiple tyrosine residues at the GABA binding pocket influence surface expression and mediate kinetics of the GABAA receptor
  Kurt T. Laha, Phu N. Tran> ;Journal of Neurochemistry. 2013 Jan 1
• A tight coupling between β₂Y97 and β₂F200 of the GABA(A) receptor mediates GABA binding.
  Tran, P.N., Laha, K.T., Wagner, D.A.> ;J Neurochem. 2011 Oct
• Join now to see all